Mohamed Mahgoub

Consultant Medical Oncologist with over 5 years of post-CCT experience and a career dedicated to providing exemplary cancer care across various NHS Trusts. Expertise lies in systemic anti-cancer therapy and immunotherapy, with a strong focus on managing treatment toxicities and enhancing patient outcomes.

Committed to evidence-based practice and patient advocacy, consistently striving for excellence in every aspect of care delivery. Adept at collaborating within diverse teams to ensure optimal patient support.

Consultant Medical Oncologist with over five years of post-CCT experience across major NHS tertiary cancer centres, including Nottingham, Leicester, Peterborough, Derby, Brighton, and York, with broad expertise in systemic anti-cancer therapy, immunotherapy, and management of treatment toxicities in lung, colorectal, breast, and gynaecological cancers. Demonstrated leadership in multidisciplinary coordination, protocol development, and service optimisation, including introducing dose-dense chemotherapy in neoadjuvant breast cancer treatment and pioneering the use of combination immunotherapy (ipilimumab/nivolumab) and Tocilizumab for severe immune-related adverse events. Actively involved in clinical research and trainee education, having served as site co-investigator for immunotherapy trials and mentor to multiple junior doctors. Recognised for delivering exceptional patient-centred care through the iWantGreatCare Certificate of Excellence (2021), currently focusing on personal development and research ahead of returning to NHS locum practice.

Completed comprehensive medical and oncology training culminating in CCT in Medical Oncology (2020) after earning MRCP (UK, 2010) and PGCert in Oncology (University of Nottingham, 2016). Gained a strong academic and clinical foundation through rotations at leading UK cancer centres, building expertise in systemic therapy, immunotherapy, and evidence-based cancer care.